Home › NDC Lookup › Ingredients › Hepatitis B Vaccine (Recombinant) Adjuvanted
📦 NDC / package directory — not a drug information page

Hepatitis B Vaccine (Recombinant) Adjuvanted NDCs, Package Codes, Strengths & Labelers

This page lists NDC package records for Hepatitis B Vaccine (Recombinant) Adjuvanted products — strengths, dosage forms, package sizes, labelers, 11-digit billing NDCs, pricing data when available, and links to each individual NDC page. It’s an NDC/package & billing directory, not a clinical drug page.

Key stats

3
Package NDCs
4
Products
4
Active listings
0
Discontinued
3
Labelers
1
Strengths
1
Dosage forms
0
With NADAC pricing

By strength, form & labeler

NDC products by strength
HEPATITIS B VIRUS SUBTYPE ADW HBSA... 4
By dosage form
INJECTION, SOLUTION 4
Top labelers
A-S Medication Solutions 2
Bamboo US BidCo LLC 1
Dynavax Technologies Corporation 1

Browse records — 4 products

Drug / product Billing NDC NADAC / unit Status
HEPLISAV-B Hepatitis B Vaccine (Recombinant) Adjuvanted 20 ug/.5mL INJECTION, SOLUTION Dynavax · NDC 43528-0003-05 · 5 SYRINGE in 1 CARTON (43528-003-05) / .5 mL in 1 SYRINGE (43528-003-01) 43528-0003-05 — On market View →
HEPLISAV-B Hepatitis B Vaccine (Recombinant) Adjuvanted 20 ug/.5mL INJECTION, SOLUTION A-S · NDC 50090-4526-00 · 5 SYRINGE in 1 CARTON (50090-4526-0) / .5 mL in 1 SYRINGE (50090-4526-1) 50090-4526-00 — On market View →
HEPLISAV-B Hepatitis B Vaccine (Recombinant) Adjuvanted 20 ug/.5mL INJECTION, SOLUTION Bamboo · NDC 83703-0048-05 · 5 SYRINGE in 1 CARTON (83703-048-05) / .5 mL in 1 SYRINGE (83703-048-01) 83703-0048-05 — On market View →
HEPLISAV-B Hepatitis B Vaccine (Recombinant) Adjuvanted 20 ug/.5mL INJECTION, SOLUTION A-S · NDC 50090-4526-00 · 5 SYRINGE in 1 CARTON (50090-4526-0) / .5 mL in 1 SYRINGE (50090-4526-1) 50090-4526-00 — On market View →
Where does this data come from?
NDC package records, strengths, forms and labelers come from the openFDA NDC Directory; pricing is CMS NADAC. Grouped by active-ingredient name. This is package/billing reference data, not clinical drug information.